Abstract:As many small bioactive molecules fulfill their functions through interacting with protein targets, the identification of such targets is crucial in understanding their mechanisms of action (MOA) and side effects. With technological advancements in target identification, it has become possible to accurately and comprehensively study the MOA and side effects of small molecules. While small molecules with therapeutic potential were derived solely from nature in the past, the remodeling and synthesis of such molecules have now been made possible. Presently, while some small molecules have seen successful application as drugs, the majority remain undeveloped, requiring further understanding of their MOA and side effects to fully tap into their potential. Given the typical promiscuity of many small molecules and the complexity of the cellular proteome, a high‐flux and high‐accuracy method is necessary. While affinity chromatography approaches combined with MS have had successes in target identification, limitations associated with nonspecific results remain. To overcome these complications, quantitative chemical proteomics approaches have been developed including metabolic labeling, chemical labeling, and label‐free methods. These new approaches are adopted in conjunction with activity‐based protein profiling (ABPP), allowing for a rapid process and accurate results. This review will briefly introduce the principles involved in ABPP, then summarize current advances in quantitative chemical proteomics approaches as well as illustrate with examples how ABPP coupled with quantitative chemical proteomics has been used to detect the targets of drugs and other bioactive small molecules including natural products.

Chemical proteomic mapping of reversible small molecule binding sites in native systems

Methods to Profile the Macromolecular Targets of Small Compounds.

Enhanced mapping of small-molecule binding sites in cells

Therapeutic Target Identification and Drug Discovery Driven by Chemical Proteomics

μMap Photoproximity Labeling Enables Small Molecule Binding Site Mapping

[Chemical Proteomics and Discovery of Drug Targets].

Identifying The Proteins To Which Small-Molecule Probes And Drugs Bind In Cells

Chemical proteomics accelerates the target discovery of natural products

Chemoproteomics and Chemical Probes for Target Discovery

Large-scale chemoproteomics expedites ligand discovery and predicts ligand behavior in cells

Activity-based Proteomic Profiling: the Application of Photoaffinity Probes in the Target Identification of Bioactive Molecules

Chemical tools to expand the ligandable proteome: diversity-oriented synthesis-based photoreactive stereoprobes

Chemical methods for the proteome-wide identification of posttranslationally modified proteins

[The Application of Small Molecule Bioactive Probes in the Identification of Cellular Targets].

Ligand and Target Discovery by Fragment-Based Screening in Human Cells

An immuno-chemo-proteomics method for drug target deconvolution

Exploiting Chemical Probes for Identifying Drug Target Proteins

Label-free target protein characterization for small molecule drugs: recent advances in methods and applications

Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes.

Proteomic methods for drug target discovery

Target Identification with Quantitative Activity Based Protein Profiling (ABPP)